Theriva Biologics, Inc. (TOVX)
0.3144
+0.07
(+29.12%)
USD |
NYAM |
Jun 11, 14:21
Theriva Biologics Market Cap : 14.43M for June 11, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| June 10, 2026 | 11.17M |
| June 09, 2026 | 11.09M |
| June 08, 2026 | 11.89M |
| June 05, 2026 | 11.71M |
| June 04, 2026 | 12.96M |
| June 03, 2026 | 13.22M |
| June 02, 2026 | 13.13M |
| June 01, 2026 | 12.94M |
| May 29, 2026 | 13.02M |
| May 28, 2026 | 14.18M |
| May 27, 2026 | 13.51M |
| May 26, 2026 | 13.63M |
| May 22, 2026 | 14.41M |
| May 21, 2026 | 13.61M |
| May 20, 2026 | 13.77M |
| May 19, 2026 | 12.25M |
| May 18, 2026 | 13.54M |
| May 15, 2026 | 13.35M |
| May 14, 2026 | 14.73M |
| May 13, 2026 | 15.14M |
| May 12, 2026 | 14.77M |
| May 11, 2026 | 15.65M |
| May 08, 2026 | 16.25M |
| May 07, 2026 | 16.52M |
| May 06, 2026 | 17.53M |
| Date | Value |
|---|---|
| May 05, 2026 | 17.44M |
| May 04, 2026 | 17.43M |
| May 01, 2026 | 17.88M |
| April 30, 2026 | 16.46M |
| April 29, 2026 | 15.14M |
| April 28, 2026 | 16.40M |
| April 27, 2026 | 16.23M |
| April 24, 2026 | 17.49M |
| April 23, 2026 | 17.49M |
| April 22, 2026 | 17.12M |
| April 21, 2026 | 15.54M |
| April 20, 2026 | 18.82M |
| April 17, 2026 | 11.80M |
| April 16, 2026 | 11.58M |
| April 15, 2026 | 11.71M |
| April 14, 2026 | 11.06M |
| April 13, 2026 | 11.62M |
| April 10, 2026 | 10.59M |
| April 09, 2026 | 11.80M |
| April 08, 2026 | 13.63M |
| April 07, 2026 | 11.45M |
| April 06, 2026 | 11.40M |
| April 02, 2026 | 10.55M |
| April 01, 2026 | 10.40M |
| March 31, 2026 | 8.986M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| ACADIA Pharmaceuticals, Inc. | 3.680B |
| Alnylam Pharmaceuticals, Inc. | 38.97B |
| Savara, Inc. | 1.080B |
| Vericel Corp. | 1.971B |
| Biogen, Inc. | 29.46B |
Market Cap Related Metrics
| PS Ratio | 24.42 |
| Price to Book Value | 0.9370 |
| Price | 0.3144 |
| Earnings Yield | -805.5% |